Tech Company Financing Transactions
EQRx Funding Round
On 1/12/2021, EQRx raised $500 million in Series B investment from private investors.
Transaction Overview
Company Name
Announced On
1/12/2021
Transaction Type
Venture Equity
Amount
$500,000,000
Round
Series B
Investors
Proceeds Purpose
Funding accelerates development of late-stage cancer therapies, pipeline expansion and business growth.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
50 Hampshire St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
EQRx operates as a biotechnology company, focused on re-engineering the process from drug discovery to patient delivery with the goal of offering a market-based solution for the rising cost of medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alexis Borisy
Chief Operating Officer
Melanie Nallicheri
Chief Technical Officer
Daniel Hoey
VP - Bus. Development
Christian Antoni
VP - Human Resources
Rona Anhalt
VP - Regulatory Affairs
Michael Doherty
VP - Regulatory Affairs
Sue Hager
Browse more venture capital transactions:
Prev: 1/12/2021: Gtmhub venture capital transaction
Next: 1/12/2021: Aulos Bioscience venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record tech company VC transactions. VC investment data records on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs